Banner Mobile

Precision Medicine / Biomarkers

With laboratory services that span the development lifecycle and industry-leading scientists with extensive drug development experience, Q2 Solutions can help you simplify and align co-development strategies to speed development and increase probability of regulatory and commercial success.

Our services include

Assay Development

With the rise of personalized medicine, drug developers are relying more on novel biomarkers from assay development companies to improve their success.

Companion Diagnostics

We have extensive companion diagnostics experience across the world, including APAC, China, EMEA and US, and we have generated lab data supporting multiple successful CDx submissions and more than 150 CDx clinical trials engagements.

Cell and Gene Therapies

With our industry-leading science and innovative solutions, we have experience partnering with clients to advance development of their cell and gene therapy trials across numerous indications and development phases.

Enterprise Biomarker Services

Expertise, experience, and tools for an optimized biomarker strategy throughout your product’s development life cycle.

Related Thought Leaders Insights

Biomarker roadmap to success

As immuno-oncology drug development involves utilizing biomarkers more for targeted therapies, you need a laboratory services partner who can work with you to develop a successful biomarker-driven...

Selection of Biomarkers for Immuno-Oncology with Patrice Hugo

In this podcast, Dr. Patrice Hugo, Chief Scientific Advisor at Q2 Solutions discusses the selection and use of biomarkers in Immuno-oncology trials and the importance of early engagement between...

Building a Best-in-Class Model for Global CDx Clinical Trial Deployment

Alan Wookey, Companion Diagnostics and Oncology Scientific Advisor at Q² Solutions along with Kristina McGuire, Sr. Director & Head of CDx and Lab operations at Regeneron and Shirin Hasan, Associate,...